Nicolás-Morala, J., Mascaraque-Checa, M., Gallego-Rentero, M., Barahona, A., Abarca-Lachen, E., Carrasco, E., . . . González, S. (2024). The m-TORC1 inhibitor Sirolimus increases the effectiveness of Photodynamic therapy in the treatment of cutaneous Squamous Cell Carcinoma, impairing NRF2 antioxidant signaling.

Nicolás-Morala, Jimena, Marta Mascaraque-Checa, María Gallego-Rentero, Andrea Barahona, Edgar Abarca-Lachen, Elisa Carrasco, Yolanda Gilaberte, Ángeles Juarranz, and Salvador González. The M-TORC1 Inhibitor Sirolimus Increases the Effectiveness of Photodynamic Therapy in the Treatment of Cutaneous Squamous Cell Carcinoma, Impairing NRF2 Antioxidant Signaling. 2024.

Nicolás-Morala, Jimena, et al. The M-TORC1 Inhibitor Sirolimus Increases the Effectiveness of Photodynamic Therapy in the Treatment of Cutaneous Squamous Cell Carcinoma, Impairing NRF2 Antioxidant Signaling. 2024.